Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05763602
PHASE4

PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

Sponsor: Loreen Herwaldt

View on ClinicalTrials.gov

Summary

The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower extremity fractures (HELEF) will decrease the patients' risk of surgical site infections (SSI), particularly those caused by Staphylococcus aureus.

Official title: Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

2000

Start Date

2022-09-15

Completion Date

2026-05-31

Last Updated

2026-02-04

Healthy Volunteers

No

Interventions

DRUG

povidone-iodine topical ointment

Intranasal povidone-iodine will be applied to the lower anterior nares (i.e. nostril) of patients undergoing HELEF orthopedic repair.

Locations (6)

Emory University

Atlanta, Georgia, United States

University of Indiana

Indianapolis, Indiana, United States

University of Iowa

Iowa City, Iowa, United States

Washington University

St Louis, Missouri, United States

University of Texas Southwestern

Dallas, Texas, United States

University of Utah

Salt Lake City, Utah, United States